¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Glycogen Synthase Kinase 3"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® glycogen ÇÑ±Û ±Û¸®ÄÚ°Õ, ´ç¿ø
¼³¸í   
  µ¿¹°¿¡¼­ Åº¼öÈ­¹°ÀÇ ÀúÀåÇüÅ·ΠÁַΠ°£¿¡ ´ëºÎºÐÀÌ ÀúÀåµÇ¾î ÀÖ°í ±ÙÀ°¿¡ Á¶±Ý ÀÖ´Ù. Æ÷µµ´çÀ¸·Î ºÐÇØµÇ¾î ÀÌ¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • synthase
    ÇÕ¼ºÈ¿¼Ò, ½ÅŸ¾ÆÁ¦
  • deposit glycogen
    ÀúÀå±Û¸®ÄÚ°Õ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • adenylate kinase
    ¾Æµ¥´Ò»êŰ³ª¾ÆÁ¦
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦
  • creatine kinase isoenzymes
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦µ¿Á¾È¿¼Ò
  • kinase
    1. Ű³ª¾ÆÁ¦ 2. Ȱ¼ºÈ¿¼Ò 3. ÀλêÈ­È¿¼Ò
  • mitogen-activated protein kinase
    ¹ÌÅä°ÕȰ¼ºÈ­´Ü¹éÁúŰ³ª¾ÆÁ¦
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦Å°³ª¾ÆÁ¦
  • protein kinase
    ´Ü¹éÁúŰ³ª¾ÆÁ¦
  • protein kinase C
    ´Ü¹éÁúŰ³ª¾ÆÁ¦C
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • kinase
    Ȱ¼ºÈ¿¼Ò, Ű³ª¾ÆÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦
  • deposit glycogen
    ÀúÀå±Û¸®ÄÚ°Õ
  • glycogen storage disease
    ´ç¿øÃàÀûº´
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen vacuole
    ´ç¿ø°øÆ÷
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • kinase
    Ȱ¼ºÈ¿¼Ò, Ű³ª¾ÆÁ¦
  • mitogen-activated protein kinase
    ºÐ¿­Á¦È°¼º´Ü¹éŰ³ª¾ÆÁ¦
  • protein kinase
    ´Ü¹éÁúŰ³ª¾ÆÁ¦
  • pyruvate kinase
    ÇÇ·çºó»ê¿°Å°³ª¾ÆÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycogen synthase
    ±Û¸®ÄÚ°ÕÇÕ¼º(ùêà÷)
  • glycogen synthase
    ´ç¿ø ÇÕ¼ºÈ¿¼Ò
  • Creatine kinase
    Å©·¹¾ÆÆ¾ Ű³ªÁ¦
  • Kinase
    Ä«À̳×ÀÌÁî
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • phosphoglycerate kinase
    Æ÷½ºÆ÷±Û¸®¼¼·¹ÀÌÆ®Å°³ªÁ¦
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦Å°³ª¾ÆÁ¦
  • pyruvate kinase
    ÇÇ·çºê»ê¿° Ű³ªÁ¦
  • Glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø(ÓØê«)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen
    ±Û¶óÀÌÄÚÀü, ´ç¿ø.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø.
  • glycogen
    ´ç¿ø, ±Û¸®ÄÚ¿À°Õ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen synthase
    ´ç¿ø ÇÕ¼ºÈ¿¼Ò
  • cystathionine beta-synthase
    ½Ã½ºÅ¸Æ¼¿À´Ñº£Å¸ÇÕ¼ºÈ¿¼Ò
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • beta-ARK : beta-adrenergic receptor kinase
    º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈ­È¿¼Ò.
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ªÁ¦
  • creatine kinase assay
    Å©·¹¾ÆÆ¾Å°³ªÁ¦ÃøÁ¤
  • creatine kinase isoenzyme
    Å©·¹¾ÆÆ¾Å°³ªÁ¦À̼ҿ£ÀÚÀÓ<µ¿È°È¿¼Ò
  • cyclic AMP-dependent kinase
    °í¸® AMP ÀÇÁ¸¼º Ű³ªÁ¦
  • deposit glycogen
    ÀúÀå(îÍíú)±Û¸®ÄÚ°Õ.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø.
  • glycogen
    ´ç¿ø, ±Û¸®ÄÚ¿À°Õ
  • glycogen
    ±Û¶óÀÌÄÚÀü, ´ç¿ø.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen degeneration
    ±Û¸®ÄÚ°Õº¯¼º(¡­Ü¨àõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycogen granule
    ´ç¿ø°ú¸³
    [¿¾ ¿ë¾î] ´ç¿ø°ú¸³
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen vacuoles
    ´ç¿ø°øÆ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen synthase
    ±Û¶óÀÌÄÚÀü ½ÅÅ×À̽º
  • synthase-phosphorylase kinase
    ½ÅÅ×À̽º-Æ÷½ºÆ÷¸±·¹À̽º Ä«À̳×À̽º
  • glycogen
    ±Û¶óÀÌÄÚÀü
  • glycogen granule
    ±Û¶óÀÌÄÚÀü °ú¸³(Ψأ)
  • glycogen phosphorylase
    ±Û¶óÀÌÄÚÀü Æ÷½ºÆ÷¸±·¹À̽º
  • glycogen storage disease
    ±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
  • amylose synthetase(synthase)
    "¾Æ¹Ð·Î½º½ÅÅ×Å×À̽º, ¾Æ¹Ð·Î½º½ÅÅ×À̽º"
  • ATP synthase
    ATP ½ÅÅ×À̽º
  • citrate synthase
    ½ÃÆ®¸£»ê(ß«) ½ÅÅ×À̽º
  • proton translocating ATP synthase
    ¾ç¼ºÀÚ(åÕàõí­) ÀüÀÌ ATP ½ÅÅ×À̽º
  • starch synthase
    ³ì¸» ½ÅÅ×À̽º
  • synthase
    "½ÅÅ×À̽º, ÇÕ¼ºÈ¿¼Ò(ùêà÷ý£áÈ)"
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×À̽º
  • AMP-kinase
    AMPÄ«À̳×À̽º
  • cAMP-dependent protein kinase
    cAMPÀÇÁ¸(ëîðí) ´Ü¹éÁú(Ó±ÛÜòõ) Ȱ¼ºÈ­È¿¼Ò(üÀàõûùý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen storage disease
    ±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AK above knee; acetate kinase; adenosine kinase; adenylate kinase; artificial kidney
CK calf kidney; casein kinase; chicken kidney; cholecystokinin; choline kinase; contralateral knee; cre...
TK thymidine kinase; transketolase; triose-kinase; tyrosine kinase
GFFS glycogen and fat-free solid
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GSK-3 beta I)/glycogen synthase kinase-3 beta
GSK3 Glycogen Synthase Kinase 3
GSK Glycogen synthase kinase
GS Glycogen synthase
NO Synthase nitric oxide synthase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • labile glycogen
    ºÒ¾ÈÁ¤ ±Û¸®ÄÚ°Õ
  • adenosine kinase
    ¾Æµ¥³ë½Å Ä«À̳×À̽º
    ATP+adenosine=ADP+AMPÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â ÀüÀÌÈ¿¼ÒÀÇ ÇϳªÀÌ´Ù. ÀÌ ¹ÝÀÀÀº
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ® Ä«À̳×À̽º
  • creatinaemia : excess of creatine in the blood.

    creatine kinase

    Å©·¹¾ÆÆ¾ Ű³ª¾ÆÁ¦
  • myotonin-protein kinase
    ¹Ì¿ÀÅä´Ñ-´Ü¹é Ű³ªÁ¦
  • nucleoside kinase
    ´ºÅ¬·¹¿À½Ãµå Ű³ª¾ÆÁ¦
    ´ºÅ¬·¹¿À½ÃµåÀÇ ATP¿¡ ÀÇÇÑ ÀλêÈ­¸¦ Ã˸ÅÇÏ´Â È¿¼Ò. ÀϹÝÀûÀ¸·Î ±âÁú ´ºÅ¬·¹¿ÀƼµåÀÇ ¿°±â¿Í ´ç ºÎºÐÀÇ ¾çÂÊÀ¸·Î ƯÀ̼ºÀ» °®´Â´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
glycogen synthase <enzyme> An enzyme of the transferase class that catalyses the reaction of udpglucose and (1,4-alpha-d-glucosyl)n to yield udp and 1,4-alpha-d-glucosyl)n+1. The reaction is highly regulated by allosteric effectors, by phosphorylation reactions, and by insulin.
Chemical name: UDPglucose:glycogen 4-alpha-D-glucosyltransferase
Registry number: EC 2.4.1.11
(12 Dec 1998)
glycogen synthase-d phosphatase <enzyme> An enzyme that catalyses the conversion of phosphorylated, inactive glycogen synthase d to active dephosphoglycogen synthase I.
Chemical name: (UDPglucose:glycogen 4-alpha-D-glucosyltransferase-D) phosphohydrolase
Registry number: EC 3.1.3.42
(12 Dec 1998)
MAP kinase kinase kinase <enzyme> From pc12 cells; reactivates map kinase kinase inactivated by protein phosphatase 2a by phosphorylation of serine residues; tak1 (tgf-beta-activated kinase 1) is a member of the mapkkk family; genbank ab006787 (mouse)
Registry number: EC 2.7.10.-
Synonym: mapkkk, tak1 mapkkk, ask1 (kinase), apoptosis signal-regulating kinase 1
(26 Jun 1999)
brancher glycogen storage disease Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme).
Synonym: brancher deficiency glycogenosis, debrancher deficiency.
(05 Mar 2000)
glycogen <biochemistry> Branched polymer of D glucose (mostly _(1-4) linked, but some _(1-6) at branch points).
Size range very variable, up to 10exp5 glucose units. Major short term storage polymer of animal cells and is particularly abundant in the liver and to a lesser extent in muscle. In the electron microscope glycogen has a characteristic asterisk or star appearance.
(18 Nov 1997)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
glycogen granule Glycogen occurring in cells as beta granule's which average about 300 A
glycogen phosphorylase <enzyme> Enzyme that catalyses the sequential removal of glycosyl residues from glycogen to yield one glucose-1-phosphate per reaction. Its activity is controlled by phosphorylation (by phosphorylase kinase).
(21 Jun 2000)
glycogen storage disease <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement.
Synonym: glycogenosis
(12 Sep 2002)
glycogen storage disease type I <disease> An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycaemia due to lack of glucose production.
Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
Inheritance: autosomal recessive.
(12 Dec 1998)
glycogen storage disease type II <disease> Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs.
(12 Dec 1998)
glycogen storage disease type III <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system).
The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type IV <disease> An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type V <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VI <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Glycogen Synthase Kinase 3 - »õâ A glycogen synthase kinase that was originally described as a key enzyme involved in glycogen metabolism. It regulates a diverse array of functions such as CELL DIVISION, microtubule function and APOPTOSIS.
    Synonyms : GSK-3, gsk-3 Gene Product
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogen
    ±Û¸®ÄÚ°Õ
  • kinase
    Ű³ª¾ÆÁ¦(È¿¼ÒÀÇ ÀÏÁ¾)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á